» Articles » PMID: 35596907

Assessing the Biocompatibility of Bovine Tendon Scaffold, a Step Forward in Tendon Tissue Engineering

Overview
Date 2022 May 21
PMID 35596907
Authors
Affiliations
Soon will be listed here.
Abstract

Tendon is a collagen-enriched, tough, and intricately arranged connective tissue that connects muscle to the bone and transmits forces, resulting in joint movement. High mechanical demands can affect normal tissues and may lead to severe disorders, which usually require replacement of the damaged tendon. In recent decades, various decellularization methods have been studied for tissue engineering applications. One of the major challenges in tendon decellularization is preservation of the tendon extracellular matrix (ECM) architecture to maintain natural tissue characteristics. The aim of the present study was to create a decellularized bovine Achilles tendon scaffold to investigate its cytocompatibility with seeded hAd-MSCs (human adipose derived-mesenchymal stem cells) and blastema tissue in vitro. Here, we describe a reliable procedure to decellularize bovine Achilles tendon using a combination of physical and chemical treatments including repetitive freeze-thaw cycles and the ionic detergent SDS, respectively. The decellularization effectiveness and cytocompatibility of the tendon scaffolds were verified by histological studies and scanning electron microscopy for up to 30 days after culture. Histological studies revealed hAd-MSC attachment and penetration into the scaffolds at 5, 10, 15 and 20 days of culture. However, a decrease in cell number was observed on days 25 and 30 after culture in vitro. Moreover, migration of the blastema tissue cells into the scaffold were shown at 10 to 25 days post culture, however, destruction of the scaffolds and reduction in cell number were observed on 30th day after culture. Our results suggest that this decellularization protocol is an effective and biocompatible procedure which supports the maintenance and growth of both hAd-MSCs and blastema cells, and thus might be promising for tendon tissue engineering.

Citing Articles

An overview of the production of tissue extracellular matrix and decellularization process.

Dehghani S, Aghaee Z, Soleymani S, Tafazoli M, Ghabool Y, Tavassoli A Cell Tissue Bank. 2023; 25(1):369-387.

PMID: 37812368 DOI: 10.1007/s10561-023-10112-1.


Decellularization of Dense Regular Connective Tissue-Cellular and Molecular Modification with Applications in Regenerative Medicine.

Data K, Kulus M, Ziemak H, Chwarzynski M, Piotrowska-Kempisty H, Bukowska D Cells. 2023; 12(18).

PMID: 37759515 PMC: 10528602. DOI: 10.3390/cells12182293.

References
1.
Abousleiman R, Reyes Y, McFetridge P, Sikavitsas V . The human umbilical vein: a novel scaffold for musculoskeletal soft tissue regeneration. Artif Organs. 2008; 32(9):735-42. DOI: 10.1111/j.1525-1594.2008.00598.x. View

2.
Khazaei M, Khazaei M, Alizadeh M, Rahmati S, Rezakhani L . Functional survey of decellularized tissues transplantation for infertile females. Cell Tissue Bank. 2021; 23(3):407-415. DOI: 10.1007/s10561-021-09979-9. View

3.
Alshaikh A, Padma A, Dehlin M, Akouri R, Song M, Brannstrom M . Decellularization and recellularization of the ovary for bioengineering applications; studies in the mouse. Reprod Biol Endocrinol. 2020; 18(1):75. PMC: 7376865. DOI: 10.1186/s12958-020-00630-y. View

4.
Andarawis-Puri N, Flatow E, Soslowsky L . Tendon basic science: Development, repair, regeneration, and healing. J Orthop Res. 2015; 33(6):780-4. PMC: 4427041. DOI: 10.1002/jor.22869. View

5.
Badylak S, Lantz G, Coffey A, Geddes L . Small intestinal submucosa as a large diameter vascular graft in the dog. J Surg Res. 1989; 47(1):74-80. DOI: 10.1016/0022-4804(89)90050-4. View